Mona Stefanos

609 total citations
4 papers, 73 citations indexed

About

Mona Stefanos is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mona Stefanos has authored 4 papers receiving a total of 73 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Mona Stefanos's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (2 papers). Mona Stefanos is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (2 papers). Mona Stefanos collaborates with scholars based in United States. Mona Stefanos's co-authors include John C. Byrd, Nyla A. Heerema, Kami J. Maddocks, Jennifer A. Woyach, Susan M. Geyer, Danelle F. James, Leslie A. Andritsos, Michael R. Grever, Amy J. Johnson and Joseph M. Flynn and has published in prestigious journals such as Journal of Clinical Oncology and Blood.

In The Last Decade

Mona Stefanos

4 papers receiving 72 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mona Stefanos United States	4	59	50	39	21	14	4	73
M Asuncion Echeveste Spain	3	61 1.0×	46 0.9×	29 0.7×	16 0.8×	13 0.9×	4	75
Mariya Salman United Kingdom	5	87 1.5×	83 1.7×	36 0.9×	14 0.7×	8 0.6×	12	91
Zachary A. Hing United States	3	62 1.1×	50 1.0×	33 0.8×	30 1.4×	42 3.0×	5	103
Tommi Salmi United States	5	86 1.5×	75 1.5×	24 0.6×	23 1.1×	8 0.6×	11	96
Ganna Usenko Ukraine	3	71 1.2×	61 1.2×	30 0.8×	22 1.0×	17 1.2×	14	84
Jennie Zhang United States	6	79 1.3×	50 1.0×	50 1.3×	16 0.8×	23 1.6×	13	103
Marina Deodato Italy	6	75 1.3×	53 1.1×	18 0.5×	22 1.0×	39 2.8×	13	99
Iryna Kriachok Ukraine	4	86 1.5×	70 1.4×	31 0.8×	31 1.5×	17 1.2×	10	93
Éric Durot France	6	65 1.1×	74 1.5×	16 0.4×	22 1.0×	11 0.8×	26	92
Krista M. Isaac United States	6	61 1.0×	60 1.2×	23 0.6×	20 1.0×	22 1.6×	11	105

Countries citing papers authored by Mona Stefanos

Since Specialization

Citations

This map shows the geographic impact of Mona Stefanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Stefanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Stefanos more than expected).

Fields of papers citing papers by Mona Stefanos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Stefanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Stefanos. The network helps show where Mona Stefanos may publish in the future.

Co-authorship network of co-authors of Mona Stefanos

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Stefanos. A scholar is included among the top collaborators of Mona Stefanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Stefanos. Mona Stefanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Mims, Alice S., Eric D. Eisenmann, Daelynn R. Buelow, et al.. (2022). A phase 1b/2 study of TP-0903 and decitabine targeting mutant TP53 and/or complex karyotype in patients with untreated acute myeloid leukemia ≥ age 60 years: Phase 1b interim results.. Journal of Clinical Oncology. 40(16_suppl). 7027–7027. 4 indexed citations

2.

Stein, Eytan M., Abigail B. Shoben, Uma Borate, et al.. (2018). Enasidenib Is Highly Active in Previously Untreated IDH2 Mutant AML: Early Results from the Beat AML Master Trial. Blood. 132(Supplement 1). 287–287. 11 indexed citations

3.

Jaglowski, Samantha, Jeffrey A. Jones, Joseph M. Flynn, et al.. (2014). A phase 1b/2 study evaluating activity and tolerability of the BTK inhibitor ibrutinib in combination with ofatumumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and related diseases.. Journal of Clinical Oncology. 32(15_suppl). 7009–7009. 7 indexed citations

4.

Jaglowski, Samantha, Jeffrey A. Jones, Joseph M. Flynn, et al.. (2012). A phase Ib/II study evaluating activity and tolerability of BTK inhibitor PCI-32765 and ofatumumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and related diseases.. Journal of Clinical Oncology. 30(15_suppl). 6508–6508. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact